There is no separate membership fee. One monthly charge per program covers the provider visit, the medication, injection supplies, shipping, and ongoing care, and the company publishes a dated rate sheet listing each program. The headline weight management figure of $179 a month buys daily liraglutide injections. Weekly or biweekly compounded semaglutide is priced considerably higher.
What the published rate sheet lists
The programs page, dated on its face, sets out each treatment with a monthly rate and, for several of them, prepaid six and twelve month alternatives. Under weight management, daily compounded liraglutide runs $179 a month with up to 90 mg supplied every 60 days including needles, syringes, and swabs. Weekly or biweekly compounded semaglutide runs $297 a month, supplied either as up to 10 mg every 70 days or up to 12.5 mg every 90 days.
Non-injectable options are priced separately. Sublingual semaglutide tablets appear at $249 a month in one program and at $179 a month under a non-injectable plan, and compounded phentermine is listed at $149 a month for thirty 37.5 mg capsules or tablets, with the sustained-release capsule unavailable in California. Oral tirzepatide and oral semaglutide are sold as prepaid blocks rather than monthly.
Prepayment is where the advertised low numbers live
The gap between the monthly rate and the paid-in-full rate is substantial. Twelve months of weekly semaglutide bills at $3,564 spread out, or $2,364 paid up front, which works out near $197 a month against $297. Twelve months of daily liraglutide is $2,148 spread out or $1,428 paid up front. Six-month blocks sit between the two.
That structure is the single most important thing to understand before comparing this provider against anyone else. A prepaid twelve-month commitment is not the same product as a monthly plan, because the published refund terms allow the company to require payment of a remaining balance unless a healthcare provider determines that treatment must stop for medical reasons. The discount is real, and it is purchased with flexibility.
Setting that structure beside other cash-pay options makes the trade clearer. Hims and Hers, Ro, and Henry Meds each package price differently, some by dose tier and some by prepaid block, and a provider such as HealthRX posts its GLP-1 medications with the monthly figure and the supply interval shown together, which is the format that lets a twelve-month total be worked out rather than guessed. Whichever provider a person lands on, the number that decides the comparison is the yearly cost at the maintenance dose, not the headline that opens the page.
| Cost line | What the published sheet says | What to confirm at checkout |
|---|---|---|
| Membership | None charged separately from the program rate | That the quoted figure is the whole recurring charge |
| Daily liraglutide | $179 monthly, up to 90 mg every 60 days | Whether the prescriber intends a daily injectable at all |
| Weekly semaglutide | $297 monthly, 10 mg per 70 days or 12.5 mg per 90 days | Which supply option applies and how long it lasts |
| Prepaid twelve months | $2,364 paid in full for semaglutide, $1,428 for liraglutide | The exit terms attached to the prepaid balance |
| Consultation fee | $30.00 inside the bundled billing, per evaluation that results in a prescription | That it is non-refundable once a prescription issues |
| Testosterone therapy | $129 monthly including labs and an aromatase inhibitor where prescribed | Whether the oral capsule option at $179 applies in your state |
| Shipping and supplies | Included in the program rate | Reshipment cost after a failed delivery |
The $179 figure and what it does not describe
The weight management page states that GLP-1 pricing starts at $179 a month. That is accurate as written, and it refers to the daily liraglutide plan rather than to weekly semaglutide. Those are different drugs on different schedules and they have been compared head to head in the published literature, with weekly semaglutide and daily liraglutide producing different results in a randomized trial of adults with overweight or obesity. Reading the entry price as the price of a weekly injectable overstates the saving by well over a hundred dollars a month.
The published sheet also carries a few internal inconsistencies, including oral blocks described as three-month supplies in the heading and as six-month schedules in the detail line, and one oral semaglutide entry whose description refers to tirzepatide tablets. None of that is evidence of bad faith, but it does mean the checkout screen, not the marketing page, is the figure to rely on.
Labs, and how this provider handles them
Testosterone therapy is listed at $129 a month with laboratory testing included, which is unusual in cash-pay telehealth and a genuine point in its favor. Guideline-level testosterone care depends on repeat morning testosterone measurement and monitoring during treatment, so a program that absorbs the panel is removing a cost that patients elsewhere pay out of pocket. The terms of service also describe an affiliated lab network with in-person draws and a remote collection option, with those costs covered under the plan.
Weight management is less explicit. Where a panel is ordered outside the affiliated network, the patient coordinates and pays for it, so a baseline metabolic and lipid panel with an A1c belongs in an annual budget even when a program does not demand one.
Comparing this rate card against the rest of the market
Compounded semaglutide, liraglutide, and tirzepatide are not FDA-approved products. Compounded preparations do not receive pre-market review for safety, effectiveness, or manufacturing quality, and that regulatory gap explains most of the distance between compounded rates and the manufacturer self-pay channels for approved medication. Medicare drug coverage has historically excluded medications used only for weight loss, which is why the cash market exists in the first place.
Rival programs publish their own rate cards, and FormBlends keeps a running page on Henry Meds pricing that sets the two structures next to each other. A competitor-authored table is useful for spotting which lines to compare, though every figure in one needs confirming against the source provider’s own dated rate sheet before it goes into a spreadsheet, since published rates in this category change without notice.
Frequently asked questions
Is there a separate membership or platform fee?
No. The published structure bundles the provider visit, medication, supplies, shipping, and continued access into one program rate. A $30.00 medical consultation fee sits inside that bundle for each evaluation that results in a prescription, and it is non-refundable once the prescription has been issued rather than billed on top.
Does the monthly price rise as the dose increases?
The published sheet prices by program and supply quantity rather than by strength, listing a maximum milligram amount per shipment interval for each plan. That caps what a plan includes, so the question to ask is what happens if a prescriber lands above the listed maximum, not whether a tier surcharge applies.
How much does paying up front actually save?
On the published twelve-month plans, paying in full brings weekly semaglutide from $3,564 to $2,364 and daily liraglutide from $2,148 to $1,428. The saving is real, and the trade is that the balance on a prepaid multi-month plan can remain payable if treatment stops for non-medical reasons.
Are laboratory tests included?
For testosterone therapy the published listing includes labs in the monthly rate. For weight management the terms describe an affiliated lab network whose costs are covered under the plan, while testing arranged outside that network is coordinated and paid for by the patient. Confirming which applies before enrollment avoids a surprise.
Can insurance or an HSA card be used?
Insurance is not billed, which is the premise of the whole model. Health savings and flexible spending cards are commonly accepted for qualifying medical expenses, subject to plan rules and substantiation, and anyone relying on that route should verify eligibility with the plan administrator rather than assume approval at checkout.
